Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 12/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17552979 | 0.96 | OPRL1 (0.34) | GAAMAPTOPRL1MEN1KMT2A | |
| SCHEMBL17356592 | 0.96 | GAA (0.37) | GAAMAPTOPRL1MEN1KMT2A | |
| SCHEMBL17356666 | 0.95 | GAA (0.38) | GAAMAPTOPRL1MEN1KMT2A | |
| SCHEMBL17356640 | 0.92 | OPRL1 (0.35) | MAPTOPRL1MEN1KMT2ADGAT1 | |
| SCHEMBL17487970 | 0.91 | GAA (0.31) | GAAMAPT | |
| SCHEMBL17356553 | 0.88 | OPRL1 (0.37) | MAPTOPRL1MEN1KMT2ADGAT1 | |
| SCHEMBL17552980 | 0.87 | DGAT1 (0.33) | OPRL1DGAT1 | |
| SCHEMBL17356671 | 0.86 | GAA (0.34) | GAAMAPTOPRL1DGAT1 | |
| SCHEMBL15256133 | 0.85 | HDAC3 (0.39) | GAAMAPTOPRL1MEN1KMT2A | |
| SCHEMBL17487980 | 0.85 | RARB (0.39) | GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9822304-B2 | Liquid crystal composition and liquid crystal display element containing the same | DIC CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-9527870-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| US-20160122646-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20160060525-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT CONTAINING THE SAME | DIC CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| US-20150368272-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368272-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | YBX3, OCIAD1, PIEZO1 | GAA 4503/4885MAPT 1138/4885OPRL1 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.